Christiane Adje-Toure
Overview
Explore the profile of Christiane Adje-Toure including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He Y, Kouabenan Y, Assoa P, Puttkammer N, Wagenaar B, Xiao H, et al.
JMIR Public Health Surveill
. 2024 Mar;
10:e50407.
PMID: 38506899
Background: The Ministry of Health in Côte d'Ivoire and the International Training and Education Center for Health at the University of Washington, funded by the United States President's Emergency Plan...
2.
Kemper K, Augusto O, Gloyd S, Akoku D, Ouattara G, Perrone L, et al.
PLOS Glob Public Health
. 2023 Sep;
3(9):e0001822.
PMID: 37708102
Routine viral load (VL) monitoring is the standard of care in Côte d'Ivoire and allows for effective treatment guidance for people living with human immunodeficiency virus (HIV) to reach viral...
3.
Fonjungo P, Lecher S, Zeh C, Rottinghaus E, Chun H, Adje-Toure C, et al.
PLoS One
. 2023 Mar;
18(3):e0282652.
PMID: 36920918
Introduction: We assessed progress in HIV viral load (VL) scale up across seven sub-Saharan African (SSA) countries and discussed challenges and strategies for improving VL coverage among patients on anti-retroviral...
4.
Hrapcak S, Pals S, Itoh M, Peters N, Carpenter D, Hackett S, et al.
Pediatr Infect Dis J
. 2023 Feb;
42(4):e102-e104.
PMID: 36728122
HIV-positive children and adolescents face gaps in viral load (VL) testing. To understand trends in pediatric/adolescent VL testing, 7 countries collected data from Laboratory Information Management Systems. Results showed increasing...
5.
He Y, Iiams-Hauser C, Assoa P, Kouabenan Y, Komena P, Pongathie A, et al.
Int J Med Inform
. 2023 Jan;
170:104977.
PMID: 36608629
Purpose: Côte d'Ivoire has a tiered public health laboratory system of 9 reference laboratories, 77 laboratories at regional and general hospitals, and 100 laboratories among 1,486 district health centers. Prior...
6.
Vojnov L, Carmona S, Zeh C, Markby J, Boeras D, Prescott M, et al.
PLoS Med
. 2022 Aug;
19(8):e1004076.
PMID: 35994520
Background: Accurate routine HIV viral load testing is essential for assessing the efficacy of antiretroviral treatment (ART) regimens and the emergence of drug resistance. While the use of plasma specimens...
7.
Minchella P, Adje-Toure C, Zhang G, Tehe A, Hedje J, Rottinghaus E, et al.
BMC Infect Dis
. 2020 Mar;
20(1):213.
PMID: 32164565
Background: Studies indicate that responses to HIV-2 treatment regimens are worse than responses to HIV-1 regimens during the first 12 months of treatment, but longer-term treatment responses are poorly described....
8.
Kim A, McDougal J, Hargrove J, Rehle T, Pillay-van Wyk V, Puren A, et al.
AIDS Res Hum Retroviruses
. 2010 Sep;
26(10):1051-61.
PMID: 20849299
Serological assays for estimating HIV-1 incidence are prone to misclassification, limiting the accuracy of the incidence estimate. Adjustment factors have been developed and recommended for estimating assay-based HIV-1 incidence in...
9.
Hanson D, Adje-Toure C, Talla-Nzussouo N, Eby P, Borget M, Kouadio L, et al.
AIDS Res Hum Retroviruses
. 2009 Apr;
25(5):489-95.
PMID: 19388820
As antiretroviral therapy continues to scale-up in developing countries, there is concern that high levels of HIV drug resistance to antiretroviral drugs will occur. Here we describe rates of emergence...
10.
Borget M, Diallo K, Adje-Toure C, Chorba T, Nkengasong J
J Clin Virol
. 2009 Apr;
45(1):72-5.
PMID: 19375979
In four of five HIV-1 and HIV-2 dually infected patients treated with efavirenz-based therapy, viral load was undetectable for HIV-1 only, with limited increase in CD4+ counts. Both viral loads...